Professor Stephen S Prime qualified in Dentistry in 1973 at the University of Birmingham and later, undertook postgraduate work at the Universities of Melbourne, Glasgow, and Bristol. His qualifications include BDS (Birmingham), PhD (Melboune), FDSRCPS (Glasgow), FRCPath (London), and DSc (Birmingham). He was appointed Emeritus Professor of Experimental Pathology and Consultant in Oral Medicine in 1992 and later served as Head of the Department of Oral and Dental Science in Bristol (2004-2007). After leaving Bristol in 2013, he has been working as an Honorary Research Fellow at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. His primary research interests relate to the pathogenesis of oral cancer. He has published widely and has been involved in the development of animal models of oral cancer, the establishment of human and animal cell lines, and additional studies to investigate the impact of TGF-B, the cancer microenvironment, and the molecular profile of target cells on cancer development.
Professor Stephen S Prime qualified in Dentistry in 1973 at the University of Birmingham and later, undertook postgraduate work at the Universities of Melbourne, Glasgow, and Bristol. His qualifications include BDS (Birmingham), PhD (Melboune), FDSRCPS (Glasgow), FRCPath (London), and DSc (Birmingham). He was appointed Emeritus Professor of Experimental Pathology and Consultant in Oral Medicine in 1992 and later served as Head of the Department of Oral and Dental Science in Bristol (2004-2007). After leaving Bristol in 2013, he has been working as an Honorary Research Fellow at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. His primary research interests relate to the pathogenesis of oral cancer. He has published widely and has been involved in the development of animal models of oral cancer, the establishment of human and animal cell lines, and additional studies to investigate the impact of TGF-B, the cancer microenvironment, and the molecular profile of target cells on cancer development.